Cited by 179Curcumin's Biomedical ApplicationsAlzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection

Clinical development of curcumin in neurodegenerative disease

Open access
Hu, Shuxin, Maiti, Panchanan, Ma, Qiulan, Zuo, Xiaohong, Jones, Mychica R, Cole, Greg M, Frautschy, Sally A·2015·Expert Review of Neurotherapeutics

Abstract

Curcumin, a polyphenolic antioxidant derived from the turmeric root has undergone extensive preclinical development, showing remarkable efficacy in wound repair, cancer and inflammatory disorders. This review addresses the rationale for its use in neurodegenerative disease, particularly Alzheimer's disease. Curcumin is a pleiotropic molecule, which not only directly binds to and limits aggregation of the β-sheet conformations of amyloid characteristic of many neurodegenerative diseases but also restores homeostasis of the inflammatory system, boosts the heat shock system to enhance clearance of toxic aggregates, scavenges free radicals, chelates iron and induces anti-oxidant response elements. Although curcumin corrects dysregulation of multiple pathways, it may exert many effects via a few molecular targets. Pharmaceutical development of natural compounds like curcumin and synthetic derivatives have strong scientific rationale, but will require overcoming various hurdles including; high cost of trials, concern about profitability and misconceptions about drug specificity, stability, and bioavailability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1586/14737175.2015.1044981

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In two phase II trials in patients with AD, curcumin had no effect on cognition or CSF biomarkers.

    “In two phase II trials151,152 in patients with AD, curcumin had no effect on cognition or CSF biomarkers149, and a third study in patients with MCI was terminated153.”

    From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [149]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A.
Affiliations
  • VA Greater Los Angeles Healthcare System (US)
  • University of California, Los Angeles (US)
Corresponding author
Frautschy, Sally A
Venue
Expert Review of Neurotherapeutics
Published
2015-06-02
Volume
15
Issue
6
Pages
629-637
ISSN
  • 1473-7175 (ISSN-L)
  • 1744-8360
OpenAlex
W1877722768
Cited by
179
References
101
Citations by year
2026: 6 · 2025: 11 · 2024: 18 · 2023: 16 · 2022: 12 · 2021: 19 · 2020: 26 · 2019: 17 · 2018: 20 · 2017: 20 · 2016: 11 · 2015: 3
FWCI
1.28
Type
journal article
Language
en
Open access
Locations
  • Expert Review of Neurotherapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 RX000669, I01 BX001257)
  • National Institute on Aging (U01AG028583, R01AG021975)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
curcumin, neurodegenerative diseases, Alzheimer's disease, amyloid fibril formation, anti-inflammatory activity, heat shock response, antioxidant activity, iron chelation, drug development, bioavailability, natural product derivatives
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Brain, Curcumin, Humans, Models, Biological, Retina, Amyloid beta-Peptides, tau Proteins, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review